28.05.2025
#priMe thanks participants, families, and partners
The priMe project extends sincere thanks to the participants and families who took part in the trial, as well as the dedicated clinical sites, investigators, and collaborators who made it possible.
Through your contributions, the priMe trial has officially been completed. Results will be available soon.
This marks an important milestone in the effort to develop safer and more effective vaccines to protect infants from tuberculosis.